Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

  title={Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.},
  author={Stefan Zeuzem and I M for the New Paradigm of HCV Therapy Meeting Part Jacobson and Tolga Baykal and Rui Tato Marinho and Fred F Poordad and Marc Bourli{\`e}re and Mark S Sulkowski and Heiner Wedemeyer and Edward Tam and Paul Desmond and Donald M. Jensen and Adrian M Di Bisceglie and Peter Varunok and Tarek I. Hassanein and Junyuan Xiong and Tami J. Pilot-Matias and Barbara DaSilva-Tillmann and Lois Larsen and Thomas J. Podsadecki and Barry Bernstein},
  journal={The New England journal of medicine},
  volume={370 17},
BACKGROUND In this phase 3 trial we evaluated the efficacy and safety of the interferon-free combination of ABT-450 with ritonavir (ABT-450/r), ombitasvir (also known as ABT-267), dasabuvir (also known as ABT-333), and ribavirin for the retreatment of HCV in patients who were previously treated with peginterferon-ribavirin. METHODS We enrolled patients with HCV genotype 1 infection and no cirrhosis who had previously been treated with peginterferon-ribavirin and had a relapse, a partial… CONTINUE READING
Highly Influential
This paper has highly influenced 12 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 37 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 231 extracted citations


Publications referenced by this paper.
Showing 1-10 of 21 references

5 REALIZE trial final results : telaprevir - based regimen for genotype 1 hepatitis C virus infection in patients with prior null response , partial response or relapse to peginterferon / ribavirin

  • S Zeuzem, P Andreone, S Pol
  • Incivek ( telaprevir ) film coated tablets : US…
  • 2014

Similar Papers

Loading similar papers…